MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acs.jmedchem.9b01398

Медицинская библиотека · Journal of medicinal chemistry · 2020

Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS Disorders.

Bonazzi Simone, Goold Carleton P, Gray Audrey, Thomsen Noel M, Nunez Jill, Karki Rajeshri G, Gorde Aakruti, Biag Jonathan D, Malik Hasnain A, Sun Yingchuan, Liang Guiqing, Lubicka Danuta, Salas Sarah, Labbe-Giguere Nancy, Keaney Erin P, McTighe Stephanie, Liu Shanming, Deng Lin, Piizzi Grazia, Lombardo Franco, Burdette Doug, Dodart Jean-Cosme, Wilson Christopher J, Peukert Stefan, Curtis Daniel, Hamann Lawrence G, Murphy Leon O

СтатьяПеревод в очереди

Аннотация

Recent clinical evaluation of everolimus for seizure reduction in patients with tuberous sclerosis complex (TSC), a disease with overactivated mechanistic target of rapamycin (mTOR) signaling, has demonstrated the therapeutic value of mTOR inhibitors for central nervous system (CNS) indications. Given that everolimus is an incomplete inhibitor of the mTOR function, we sought to develop a new mTOR inhibitor that has improved properties and is suitable for CNS disorders. Starting from an in-house purine-based compound, optimization of the physicochemical properties of a thiazolopyrimidine series led to the discovery of the small molecule 7, a potent and selective brain-penetrant ATP-competitive mTOR inhibitor. In neuronal cell-based models of mTOR hyperactivity, 7 corrected the mTOR pathway activity and the resulting neuronal overgrowth phenotype. The new mTOR inhibitor 7 showed good brain exposure and significantly improved the survival rate of mice with neuronal-specific ablation of the Tsc1 gene. These results demonstrate the potential utility of this tool compound to test therapeutic hypotheses that depend on mTOR hyperactivity in the CNS.

Для цитирования: Bonazzi Simone, Goold Carleton P, Gray Audrey, Thomsen Noel M, Nunez Jill, Karki Rajeshri G, Gorde Aakruti, Biag Jonathan D, Malik Hasnain A, Sun Yingchuan, Liang Guiqing, Lubicka Danuta, Salas Sarah, Labbe-Giguere Nancy, Keaney Erin P, McTighe Stephanie, Liu Shanming, Deng Lin, Piizzi Grazia, Lombardo Franco, Burdette Doug, Dodart Jean-Cosme, Wilson Christopher J, Peukert Stefan, Curtis Daniel, Hamann Lawrence G, Murphy Leon O. Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS Disorders.. Journal of medicinal chemistry. 2020. DOI: 10.1021/acs.jmedchem.9b01398.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.